Abstract
We have devised a barcoding strategy to recapitulate cancer evolution through the emergence of subclonal mutations of interest, whose effects can be monitored in a dynamic manner. This approach can be easily adapted for a variety of applications, including combined modeling of multiple mechanisms of drug resistance or repair of oncogenic driver mutations in addicted cancer cells.
| Original language | English |
|---|---|
| Article number | e1227894 |
| Journal | Molecular and Cellular Oncology |
| Volume | 3 |
| Issue number | 6 |
| DOIs |
|
| State | Published - 1 Nov 2016 |
Keywords
- ALK
- APC
- CRISPR/Cas9
- EGFR
- TP53
- genetic barcoding
- non-small cell lung cancer
- resistance
- tumor heterogeneity